Mr Christopher Ogden, Consultant Urologist
Mr Christopher Ogden
Consultant Urologist
Mr Christopher Ogden MB BS MS FRCSEd FRCSEng FRCSUrol FEBU
Consultant Urologist
Mr Christopher Ogden
Consultant Urologist MB BS MS FRCSEd FRCSEng FRCSUrol FEBU
Recommendations for Mr Ogden
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
Make an appointment
Address
-
The London Urologists
18 Devonshire Street, London, W1G 7AQ
-
Devonshire Diagnostic Centre
16 Devonshire Street, Marylebone, London, W1G 7AF
-
The Princess Grace Hospital
42–52 Nottingham Place, London, W1U 5NY
-
Chelsea Outpatient Centre
280 King's Road, London, SW3 5AW
-
Telephone or video consultation
Virtual
About Mr Christopher Ogden
GMC number: 2957661
Year qualified: 1984
Place of primary qualification: University of London
Initial consultation fee: £330
Follow up consultation fee: £230
Mr Christopher Ogden is a renowned consultant uro-oncologist at The Harley Street Clinic and The Princess Grace Hospital, both part of HCA Healthcare UK. He is celebrated for his pioneering work in robotic surgery, having performed the first private robotic surgery in the UK. Since then, he has conducted thousands of robotically assisted procedures, establishing himself as a high-volume, experienced surgeon.
Mr Ogden's expertise extends to transperineal laser ablation (TPLA) of the prostate, a micro-invasive treatment offering excellent outcomes with minimal risk. He was the first consultant in the UK to perform this procedure and remains one of the few globally proficient in it. His work in TPLA was presented at the BAUS international congress in 2023, showcasing significant patient benefits and no complications.
In collaboration with Dr Jihad Kaouk from the Cleveland Clinic, Mr Ogden performed Europe’s first radical robotic perineal prostatectomy. This innovative approach has been developed in partnership with the NHS and reviewed positively at University College London Hospitals.
Mr Ogden was also among the first to use high intensity focused ultrasound (HIFU) for prostate cancer treatment. He has compared whole gland HIFU with robotic surgery and co-authored a paper on focal HIFU outcomes, published in the Journal of Urology.
A respected trainer in minimally invasive procedures, Mr Ogden continues to advance the field through research and education. He has presented numerous papers on TPLA and transperineal robot-assisted radical prostatectomy using the DaVinci Xi surgical system. His dedication to improving patient care and surgical outcomes makes him a leading figure in uro-oncology.
Areas of expertise
- Benign prostatic hyperplasia (BPH)
- Bladder cancer
- Bladder instillation
- Bladder pain
- Blood in urine (haematuria)
- Circumcision
- Cystoscopy
- Epididymal cysts
- Focal therapy for prostate cancer
- High-intensity focused ultrasound (HIFU)
- Kidney stone prevention
- Kidney stones
- MRI of prostate
- Nerve-sparing prostatectomy
- Orchidectomy
- Prostate biopsy
- Prostate cancer
- Prostate cancer diagnostics
- Prostatectomy (radical)
- Prostatectomy (robotic)
- Prostatectomy (TURP)
- Prostatitis (prostate swelling)
- PSA testing
- Retzius-sparing radical prostatectomy
- Robotic surgery
- Testicular pain
- Transperineal laser ablation (TPLA)
- Transrectal ultrasound (TRUS)
- Transurethral resection of a bladder tumour (TURBT)
- Urethral and bladder neck sparing in prostatectomy
- Urinary incontinence
- Urinary retention
- Urinary tract infections (UTIs)
- Urological (genitourinary) cancers
- Varicocele
- Vasectomy (male sterilisation)
Frequently asked questions
Why did you decide to become a Consultant Urologist ?
I became a Urologist because of the diversity of the specialty. When I started in Urology in 1986, 40 years ago, it was a surgical specialty that also managed the whole pathway, both diagnosis and treatment. That is unlike most other surgical specialties, where the surgeon operates and allied physicians look after the diagnostics: in Gastroenterology you have Gastroenterologists and Gastrointestinal Surgeons, and in Cardiology you have Cardiologists and Cardiac Surgeons. In Urology, the Urologist is a surgeon who also does the diagnostic work, so you are involved in the whole process, from diagnosis through to offering both medical and surgical treatment options. The other reason was how hugely diverse the specialty was. During my house job in Urology we did kidney transplants, major cancer surgery, gender reassignment surgery, microsurgery and endoscopy, all within one specialty. Those diverse applications and treatment options were enduringly fascinating, and they set me on what has become a 40-year road in Urology.
What are the common symptoms that your patients tend to present with?
The majority of patients who present with prostate disorders have noticed a change in their voiding pattern: a slowing of the urinary stream, getting up at night more often, perhaps hesitancy, or urgency and having to rush to the loo. Men become more aware of these symptoms as they get older, and that prompts them to see their GP and be referred to assess whether they have a significant prostate enlargement or another problem. The other common reason for referral is a routine blood test, either through a health screen or general practice, showing a raised PSA, which prompts referral for further investigation. So it is a combination of urinary symptoms, a raised PSA, or blood in the urine.
What are the treatments that you're able to offer your patients?
The diagnostic options are very varied. We are fortunate in the private setting to have access to many new diagnostic and treatment options, and in fact we have pioneered treatments here that have then been taken up by the NHS. The diagnostics are state of the art, particularly for prostate cancer, with new tests and much more specific biopsy techniques that use fusion AI software to target the cancer precisely within the prostate. Very importantly, the right diagnostic tool also makes it possible to offer patients the least invasive, least morbid and most effective treatment options, so it is a critical part of the pathway.
What are your areas of sub-specialist interest?
I am a General Urologist, but my main interest is in prostate disorders, both benign and malignant. My research was on microwave therapy as a minimally invasive treatment for benign prostatic hypertrophy, and I went on to evolve and pioneer robotic surgery for prostate cancer and high intensity focused ultrasound (HIFU), which we subsequently developed as a focal treatment for prostate cancer. Both technologies were pioneered by me at The Princess Grace Hospital more than 20 years ago and have since been adopted as a standard of care for NHS patients and for patients generally in the UK. More recently we have also pioneered transperineal laser ablation (TPLA), a new minimally invasive way of treating both benign prostate enlargement and prostate cancer. It is a single treatment, done as a day case, and can be carried out under local anaesthetic. I introduced it at The Princess Grace Hospital three years ago and we continue to offer it.
Professional memberships
Articles by Mr Christopher Ogden
Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer
An exploratory study of dose escalation versus standard focal high intensity focused ultrasound for treating non-metastatic prostate cancer
Evaluation of functional outcomes following a second focal-HIFU in men with primary localised, non-metastatic prostate cancer; results from the high intensity focused ultrasound evaluation and assessment of treatment (heat) registry
A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer
Mp30-11 predictors of poor functional outcomes after focal high intensity focussed ultrasound (HIFU)










